TITLE

Gastric ischemia: an undescribed manifestation of NSAID abuse

AUTHOR(S)
Chalasani, Rambabu; Khurana, Vikas
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS195
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Gastric Ischemia: An Undescribed Manifestation of NSAID Abuse" by Rambabu Chalasani and Vikas Khurana is presented.
ACCESSION #
66954920

 

Related Articles

  • Aspirin plus esomeprazole reduced recurrent ulcer bleeding more than clopidogrel in high-risk patients. Peterson, Walter L. // ACP Journal Club;Jul/Aug2005, Vol. 143 Issue 1, p24 

    This article presents information on a study related to clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. In patients with previous aspirin-induced ulcer bleeding, the addition of esomeprazole to aspirin was better than changing to clopidogrel for decreasing...

  • Short-term use of NSAIDs increased risk for ischemic, hemorrhagic stroke.  // Cardiology Today;Sep2010, Vol. 13 Issue 9, p38 

    The article discusses a study on the negative effect of the short-term use of selective and nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) published in a 2010 issue of "Stroke", results of which show that the drugs cause an increased risk for ischemic and hemorrhagic stroke.

  • N-PEP-12 — a novel peptide compound that protects cortical neurons in culture against different age and disease associated lesions. Windisch, M.; Hutter-Paier, B.; Grygar, E.; Doppler, E.; Moessler, H. // Journal of Neural Transmission;Oct2005, Vol. 112 Issue 10, p1331 

    The neuroprotective potency of N-PEP-12, a novel, proprietary compound consisting of biopeptides and amino acids was investigated. Lesion models have been applied in neuronal cultures of embryonic chicken cortex, pre-treated with N-PEP-12 from the first day onwards. On day 8 in vitro neurons...

  • Platelet Activation in Bypass Surgery for Critical Limb Ischemia. Mohan, Irwin V.; Mikhailidis, Dimitri P.; Stansby, Gerard P. // Vascular & Endovascular Surgery;Aug/Sep2007, Vol. 41 Issue 4, p322 

    Platelet activation contributes to graft occlusion after bypass surgery. This study investigated platelet activation status before, during, and after bypass. Blood was taken preoperatively from patients undergoing femoro-popliteal bypass and at incision, after dissection, after ischemia, after...

  • Use of Antiplatelet Drugs in Secondary Prevention in Older Persons With Atherothrombotic Disease. Aronow, Wilbert S. // Journals of Gerontology Series A: Biological Sciences & Medical ;May2007, Vol. 62 Issue 5, p518 

    Unless there are contraindications to the use of aspirin, aspirin should be used in treating patients with acute myocardial infarction (MI) and continued indefinitely to reduce vascular death, nonfatal MI, and nonfatal stroke. Clopidogrel added to aspirin has been shown to be beneficial in the...

  • A prediction rule identified patients with atrial Fibrillation at low risk of stroke while taking aspirin. Hankey, Graeme J. // Evidence Based Medicine;Jan/Feb2004, Vol. 9 Issue 1, p29 

    The article presents information on the effectiveness of asprin for patients with atrial fibrillation. Overall, 166 patients had a stroke or transient ischaemic attack (TIA) during 4689 person years (PYs) of observation for an incident rate of 3.5 events per 100 PYs. In the derivation group,...

  • Primary and Secondary Stroke Prevention with Antiplatelet Drugs. Diener, Hans-Christoph // Current Pharmaceutical Design;Apr2006, Vol. 12 Issue 10, p1293 

    Aspirin is not effective in the primary prevention of stroke. Patients with TIA or ischemic stroke carry a risk of recurrent stroke between 5 and 20% per year. In patients with TIA or ischemic stroke of noncardiac origin antiplatelet drugs are able to decrease the risk of stroke by 11-15% and...

  • Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged ≥80 years. Nilsson, Sven E.; Johansson, Boo; Takkinen, Sanna; Berg, Stig; Zarit, Steven; McClearn, Gerald; Melander, Arne // European Journal of Clinical Pharmacology;Aug2003, Vol. 59 Issue 4, p313 

    Objective. It has been reported that aspirin and other non-steroidal anti-inflammatory drugs (NSAID) may protect against dementia of Alzheimer's type and/or vascular dementia. However, co-morbidity and the dose of aspirin may be critical. A major indication for low-dose aspirin is prophylaxis...

  • Drug Therapy for Acute Ischaemic Stroke: Risks versus Benefits. Lindley, R.I. // Drug Safety;Nov1998, Vol. 19 Issue 5, p373 

    Stroke is a very common medical emergency that, until recently, had no specific treatment. Following the results of several major trials (including 2 ‘mega-trials’), aspirin (acetylsalicylic acid) can be recommended for the majority of patients with acute ischaemic stroke. While the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics